FALCO HOLDINGS Co., Ltd. (4671.T) JPX
2,657.00
+152(+6.07%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
2,657.00
+152(+6.07%)
Currency In JPY
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1117
First IPO Date
October 29, 2004
| Name | Title | Pay | Year Born |
| Hisayuki Ohba | Executive Officer, GM of Pharma Business Div. & Director | 0 | 1969 |
| Shuhei Kuroda | Executive Officer & Director | 0 | 1973 |
| Tadashi Yasuda | President, Executive Officer & Chairman | 0 | 1958 |
| Tetsuo Goda | GM of Corporate Planning Office & Director | 0 | 1966 |
| Yoichi Kawata | Managing Executive Officer, GM of Clinical Business Office & Director | 0 | 1962 |
| Takafumi Fukui | Executive Vice President & Director | 0 | 1965 |
| Kei Shimada | Executive Officer & Director | 0 | 1973 |
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.